Clovis Oncology Submits Applications for Rubraca® Label Expansion in the US and European Union as First-line Maintenance Treatment in Women with Advanced Ovarian Cancer

Submissions based on data from the Phase 3 ATHENA trial evaluating Rubraca monotherapy versus placebo (ATHENA-MONO) presented at ASCO 2022 The ATHENA-MONO trial met its primary endpoint, showing Rubraca monotherapy versus placebo improved progression-free survival (PFS) by investigator assessment in both populations in the primary efficacy analyses: HRD-positive and all patients randomized (ITT) Safety of … [Read more…]

METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi

CAMBRIDGE, Mass.–(BUSINESS WIRE)–METiS Therapeutics, a Boston-area company integrating drug discovery and delivery with AI and machine learning, today announced they have entered a license agreement with Voronoi, Inc., a Korean company focused on precision medicine. Under the terms of this license agreement, METiS will receive exclusive license to develop and commercialize Voronoi’s pan-RAF inhibitor program … [Read more…]

Castle Biosciences Honored with a 2022 AZBio Fast Lane Award from the Arizona Bioindustry Association

FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #AZBio–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received an AZBio Fast Lane Award from the Arizona Bioindustry Association (AZBio). “Castle Biosciences is working to transform how diseases are managed with the goal of making life better for patients,” … [Read more…]

NovaBay Pharmaceuticals to Present at the Virtual Life Sciences Investor Forum

EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that management will present at the Virtual Life Sciences Investor Forum on Thursday, September 15, 2022 at 1:00 p.m. Eastern time (10:00 a.m. Pacific Time). Management will be holding investor one-on-one meetings on … [Read more…]

Virtuoso Surgical Announces First Public Offering of Common Stock to Advance its Revolutionary Robotic System for Endoscopic Surgery

NASHVILLE, Tenn.–(BUSINESS WIRE)–Virtuoso Surgical, Inc., a Nashville-based medical device company, announced today that its $20 million stock offering has become effective after review by the United States Securities and Exchange Commission and the Financial Industry Regulatory Authority. Virtuoso Surgical has developed a robotic surgery system that radically improves minimally invasive endoscopic surgery. Virtuoso uses patented … [Read more…]

SpectrumX Announces Significant Updates at Knutsford Production Facility

Critical upgrades allow the Company to produce SPC-069 drug substance for clinical trials Other new additions to the facility include dedicated quality control room, microbiology laboratory and office space KNUTSFORD, England–(BUSINESS WIRE)–SpectrumX, a UK-based healthcare and pharmaceutical company, announced today that recent upgrades at its state-of-the-art production facility in Knutsford, Cheshire, will allow the Company … [Read more…]

Alnylam Announces Pricing of Offering of $900 Million Convertible Senior Notes

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (“Alnylam”) (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today the pricing of its previously announced private offering of $900 million aggregate principal amount of 1.00% convertible senior notes due 2027 (the “notes”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act … [Read more…]

Within3 Announces the Evolution of Industry-First Insights Management Platform

The amplified iteration of the platform transforms the potential for market visibility, research collaboration and business decision-making in life science CLEVELAND & LONDON–(BUSINESS WIRE)–Within3 announces new enhancements to its industry-first insights management platform for pharmaceutical and medical device companies. With more than 40 engagement applications across the platform, life science organizations can now better understand … [Read more…]

H.I.G. Capital Completes Recapitalization of Navitas Life Sciences

MIAMI–(BUSINESS WIRE)–#BlueChipClients–H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences (“Navitas” or the “Company”). Headquartered in Princeton, NJ, Navitas is a global technology-enabled clinical research organization (CRO) providing outsourced … [Read more…]

Global EMC Filtration Market (2022 to 2027) – Increasing Adoption of Electric Vehicles Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “EMC Filtration Market by Product Type (EMC Filters (1-Phase EMC Filters, 3-Phase EMC Filters, DC Filters, IEC Inlets, Chokes), Power Quality Filters (Passive Harmonic Filters, Active Harmonic Filters, Output Filters, Reactors)) – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The EMC filtration market is expected to grow from USD … [Read more…]